arrow
W

Wataru Munakata

Department of Hematology
H指数:23
被引数:3,469

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world outcomes of chimeric antigen receptor T-cell therapy with pembrolizumab as holding and/or bridging therapy in relapsed/refractory primary mediastinal large B-cell lymphoma

嵌合抗原受体T细胞疗法联合帕博利珠单抗作为维持和/或桥接疗法在复发/难治性原发纵隔大B细胞淋巴瘤中的真实世界疗效

2026-04-130
PRE
Clonal analysis of a case with fluid overload-associated large B-cell lymphoma evolving from primary large B-cell lymphoma of the central nervous system

一例液体超负荷相关的大B细胞淋巴瘤(由中枢神经系统原发性大B细胞淋巴瘤演变而来)的克隆分析

2026-03-110
OAAI
T-cell fitness, metabolic tumor volume, and serum LDH levels are associated with response to axicabtagene ciloleucel

T细胞活力、代谢肿瘤体积和血清LDH水平与axicabtagene ciloleucel的反应相关

2026-01-010
PRE
Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER)

高风险中枢神经系统复发风险的初诊弥漫大B细胞淋巴瘤的pola-R-CHP/高剂量甲氨蝶呤/鞘内注射 vs. pola-R-CHP/鞘内注射的随机III期研究方案摘要:JCOG2201 (PREMIER)

2025-12-010
OA
Correlation with CD79B expression and clinicopathological parameters including cell of origin, CD79A and CD19 expression, and CD79B mutation in diffuse large B-cell lymphoma

与CD79B表达及临床病理参数(包括起源细胞、CD79A和CD19表达以及CD79B突变)在弥漫性大B细胞淋巴瘤中的相关性

2025-06-140
PRE
A phase II study of zandelisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma: ME-401-K02 study

一项关于zandelisib在复发或难治性惰性非霍奇金淋巴瘤患者中的II期研究:ME-401-K02研究

2025-01-080
OAAI
Whole exome sequencing analysis of a patient with myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions with ETV6::LYN fusion gene

嗜酸性粒细胞增多和酪氨酸激酶基因与ETV6::LYN融合基因融合的骨髓/淋巴肿瘤患者的全外显子组测序分析

2024-12-200
PRE
Number of Sites of Involvement Predicts Central Nervous System Relapse in Patients with Localized Extranodal Natural Killer/T-Cell Lymphoma

累及部位数量可预测局限性结外自然杀伤/T细胞淋巴瘤患者的中枢神经系统复发。

BLOOD
IF23.1
2024-11-050
PRE
Comparison of Clinical Characteristics and Prognosis between Aggressive NK-Cell Leukemia and Advanced-Stage Extranodal NK/T-Cell Lymphoma

比较侵袭性NK细胞白血病与晚期结外NK/T细胞淋巴瘤的临床特征及预后

BLOOD
IF23.1
2024-11-050
PRE
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma
2023-11-286
OAAI